TerminatedPhase 3NCT00637468

EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye

Studying Central retinal artery occlusion

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University Hospital Freiburg
Principal Investigator: Martin Schumacher, Professor
Department of Neuroradiology, University Medical Center Freiburg
Intervention: Intravenous injection of heparin(drug)
Enrollment: 84 enrolled
Eligibility: 18-75 years · All sexes
Timeline: 2002

Study locations (21)

Universityhospital Graz, Graz, Austria
Universityhospital Innsbruck, Innsbruck, Austria
Allgemeines Krankenhaus Wien, Vienna, Austria
University Medical Center Freiburg, Freiburg im Breisgau, Baden-Wurttemberg, Germany
Universityhospital of RWTH Aachen, Aachen, Germany
Klinikum Augsburg, Augsburg, Germany
Universityhospital Bonn, Bonn, Germany
UKL Essen, Essen, Germany
Allgemeines Krankenhaus Hamburg Altona, Hamburg, Germany
UKE Hamburg, Hamburg, Germany
Medizinische Hochschule Hannover, Hanover, Germany
Universityhospital Homburg/Saar, Homburg/Saar, Germany
Universityhospital Kiel, Kiel, Germany
Medizinische Universität zu Lübeck, Lübeck, Germany
Universityhospital Magdeburg, Magdeburg, Germany
+6 more locations on ClinicalTrials.gov

Collaborators

Boehringer Ingelheim

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00637468 on ClinicalTrials.gov

Other trials for Central retinal artery occlusion

Additional recruiting or active studies for the same condition.

See all trials for Central retinal artery occlusion →

← Back to all trials